Login / Signup

Quantitative LC-MS Provides No Evidence for m6 dA or m4 dC in the Genome of Mouse Embryonic Stem Cells and Tissues.

Sarah SchiffersCharlotte EbertRené RahimoffOlesea KosmatchevJessica SteinbacherAlexandra-Viola BohneFabio SpadaStylianos MichalakisJoerg NickelsenMarkus MüllerThomas Carell
Published in: Angewandte Chemie (International ed. in English) (2017)
Until recently, it was believed that the genomes of higher organisms contain, in addition to the four canonical DNA bases, only 5-methyl-dC (m5 dC) as a modified base to control epigenetic processes. In recent years, this view has changed dramatically with the discovery of 5-hydroxymethyl-dC (hmdC), 5-formyl-dC (fdC), and 5-carboxy-dC (cadC) in DNA from stem cells and brain tissue. N6 -methyldeoxyadenosine (m6 dA) is the most recent base reported to be present in the genome of various eukaryotic organisms. This base, together with N4 -methyldeoxycytidine (m4 dC), was first reported to be a component of bacterial genomes. In this work, we investigated the levels and distribution of these potentially epigenetically relevant DNA bases by using a novel ultrasensitive UHPLC-MS method. We further report quantitative data for m5 dC, hmdC, fdC, and cadC, but we were unable to detect either m4 dC or m6 dA in DNA isolated from mouse embryonic stem cells or brain and liver tissue, which calls into question their epigenetic relevance.
Keyphrases